Developing A Decision Aid For Patients With Diabetes, Testing New TB Vaccines

Main Category: Diabetes
Also Included In: Infectious Diseases / Bacteria / Viruses;  Immune System / Vaccines
Article Date: 08 Aug 2007 - 12:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

FROM THE PLoS MEDICINE MAGAZINE SECTION:

Developing a decision aid for patients with diabetes

Victor Montori (Mayo Clinic) and colleagues share lessons learned from their development of 'Statin Choice,' a decision aid for patients with diabetes who are considering using cholesterol-lowering drugs called statins to reduce their cardiovascular risk.

Citation: Montori VM, Breslin M, Maleska M, Weymiller AJ (2007) Creating a conversation: Insights from the development of a decision aid. PLoS Med 4(8): e233.

CLICK HERE TO ACCESS THE PUBLISHED PAPER

- Caption: "Decision aids can be designed to create a conversation about medications." (Created by Matt Maleska)

CONTACT:
Victor Montori
Mayo Clinic College of Medicine
200 First Street SW
Rochester, MN 55905
United States of America

Testing new TB vaccines--what are the regulatory issues?

In a policy paper in this week's PLoS Medicine, Michael Brennan (US Food and Drug Administration) and colleagues lay out the regulatory challenges for testing and introducing investigative TB vaccines into countries where the disease is endemic.

Citation: Brennan MJ, Fruth U, Milstien J, Tiernan R, Nishioka SdA, et al. (2007) Development of new tuberculosis vaccines: A global perspective on regulatory issues. PLoS Med 4(8): e252.

CLICK HERE TO ACCESS THE PUBLISHED PAPER

CONTACT:
Michael Brennan
Center for Biologics Evaluation and Research
Office of Vaccines Research and Review
Associate Director of Research, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research
Food and Drug Administration
1401 Rockville Pike, Suite 200N/HFM431
Rockville, MD 20852-1448
United States of America

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

About PLoS Medicine

PLoS Medicine is an open access, freely available international medical journal. It publishes original research that enhances our understanding of human health and disease, together with commentary and analysis of important global health issues. For more information, visit http://www.plosmedicine.org/

About the Public Library of Science

The Public Library of Science (PLoS) is a non-profit organization of scientists and physicians committed to making the world's scientific and medical literature a freely available public resource. For more information, visit http://www.plos.org/

Source: Andrew Hyde
Public Library of Science